212 related articles for article (PubMed ID: 17349582)
1. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Mutlu AD; Cavallin LE; Vincent L; Chiozzini C; Eroles P; Duran EM; Asgari Z; Hooper AT; La Perle KM; Hilsher C; Gao SJ; Dittmer DP; Rafii S; Mesri EA
Cancer Cell; 2007 Mar; 11(3):245-58. PubMed ID: 17349582
[TBL] [Abstract][Full Text] [Related]
2. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
[TBL] [Abstract][Full Text] [Related]
3. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
4. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
5. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
6. High-throughput sequencing analysis of a "hit and run" cell and animal model of KSHV tumorigenesis.
Naipauer J; Salyakina D; Journo G; Rosario S; Williams S; Abba M; Shamay M; Mesri EA
PLoS Pathog; 2020 Jun; 16(6):e1008589. PubMed ID: 32603362
[TBL] [Abstract][Full Text] [Related]
7. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.
Dai L; Trillo-Tinoco J; Chen Y; Bonstaff K; Del Valle L; Parsons C; Ochoa AC; Zabaleta J; Toole BP; Qin Z
Oncotarget; 2016 Jan; 7(4):3806-18. PubMed ID: 26675551
[TBL] [Abstract][Full Text] [Related]
8. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.
Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z
Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells.
Watanabe T; Sugaya M; Atkins AM; Aquilino EA; Yang A; Borris DL; Brady J; Blauvelt A
J Virol; 2003 Jun; 77(11):6188-96. PubMed ID: 12743275
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.
Hu J; Jham BC; Ma T; Friedman ER; Ferreira L; Wright JM; Accurso B; Allen CM; Basile JR; Montaner S
Oral Oncol; 2011 May; 47(5):371-5. PubMed ID: 21421336
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
[TBL] [Abstract][Full Text] [Related]
13. Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication.
Ashlock BM; Ma Q; Issac B; Mesri EA
PLoS One; 2014; 9(1):e87324. PubMed ID: 24489895
[TBL] [Abstract][Full Text] [Related]
14. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
15. KSHV downregulation of galectin-3 in Kaposi's sarcoma.
Alcendor DJ; Knobel SM; Desai P; Zhu WQ; Vigil HE; Hayward GS
Glycobiology; 2010 May; 20(5):521-32. PubMed ID: 20040515
[TBL] [Abstract][Full Text] [Related]
16. Initiation of angiogenic Kaposi's sarcoma lesions.
Hayward GS
Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
[TBL] [Abstract][Full Text] [Related]
18. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
19. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Rose PP; Bogyo M; Moses AV; Früh K
J Virol; 2007 Aug; 81(15):8050-62. PubMed ID: 17507477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
